177 related articles for article (PubMed ID: 36869387)
1. Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects.
Li X; Wang C; Shi P; Liu Y; Tao Y; Lin P; Li T; Hu H; Sun F; Liu S; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Mar; 24(1):14. PubMed ID: 36869387
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence study of domperidone dry suspension in healthy Chinese subjects under fasted and fed conditions: An open-label, randomized, single-dose, crossover trial.
Wu L; Huang Q; Lin M; Kai J; Huang Y; Zhai Y; Liu J; Shentu J
Int J Clin Pharmacol Ther; 2023 Jul; 61(7):320-328. PubMed ID: 36999513
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers.
Cho SH; Kim CW; Nam MS
Infect Chemother; 2020 Jun; 52(2):204-211. PubMed ID: 32468741
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence Study of Palbociclib Capsules in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Chu NN; Zhang L; Wang J; Gu X; Ding Y; Huang K; Que LL; He Q
Clin Drug Investig; 2022 Jan; 42(1):53-63. PubMed ID: 34837169
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Bioequivalence of Two Formulations of Febuxostat 40-Mg and 80-Mg Tablets: A Randomized, Open-Label, 4-Way Crossover Study in Healthy Chinese Male Volunteers.
Luo Z; Nan F; Miao J; Chen Z; Li M; Liang M
PLoS One; 2016; 11(3):e0150661. PubMed ID: 26974539
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
Wu Q; Wang X; Chen Q; Zou Y; Xu X; Li T; Yu C; Zhu F; Zhang KE; Jia J; Liu Y
Drug Des Devel Ther; 2020; 14():4221-4230. PubMed ID: 33116410
[TBL] [Abstract][Full Text] [Related]
9. Single-dose bioequivalence assessment of two formulations of polysaccharide iron complex capsules in healthy adult male Chinese volunteers: A sequence-randomized, double-blind, two-way crossover study.
Zhang YY; Liu JH; Su F; Lui YT; Li JF
Curr Ther Res Clin Exp; 2009 Apr; 70(2):104-15. PubMed ID: 24683222
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Bioequivalence of Cefprozil for Suspension and Granule Formulation in Healthy Chinese Volunteers: Two Single-Dose Crossover Studies.
Lin PP; Wang CJ; Liu YP; Li T; Gao XM; Ma YP; Shi P; Li X; Wang LX; Cao Y
Adv Ther; 2021 Feb; 38(2):1130-1142. PubMed ID: 33340343
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
[TBL] [Abstract][Full Text] [Related]
12. A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm
Lin S; Lou Y; Hao R; Shao Y; Yu J; Fang L; Bao M; Yi W; Zhang Y
Front Pharmacol; 2024; 15():1328142. PubMed ID: 38828454
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of cefalexin in healthy Chinese subjects.
Lv X; Zhong G; Yao H; Wu J; Ye S
Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
[TBL] [Abstract][Full Text] [Related]
15. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
16. A randomized, crossover study to determine bioequivalence of two brands of dexibuprofen 400 mg tablets in healthy Asian adult male subjects of Indian origin.
Menon S; Kadam N; Patil G; Mhatre P
Int J Clin Pharmacol Ther; 2008 Jan; 46(1):48-54. PubMed ID: 18218298
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and bioequivalence of two methylprednisolone tablet formulations in healthy Chinese subjects under fasting and fed conditions.
Fan L; Zhang P; Gan C; Huang Q; Shen Z; Xiao X; Yang Y; Qiu D; Mai G; Shentu J
Int J Clin Pharmacol Ther; 2023 Jan; 61(1):37-44. PubMed ID: 36278293
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioequivalence study of two digoxin formulations after single-dose administration in healthy Chinese male volunteers.
Zhang XY; Tian Y; Zhang ZJ; Rui JZ; Cao XM
Arzneimittelforschung; 2011; 61(11):601-4. PubMed ID: 22232847
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers.
Kale P
Front Pharmacol; 2014; 5():98. PubMed ID: 24847268
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence evaluation of two acipimox tablets: a single-dose, randomized-sequence, two-way crossover study in healthy Chinese male volunteers.
Huang J; Chen R; Wei C; Li R; Yuan G; Liu X; Wang B; Guo R
Drug Res (Stuttg); 2013 Feb; 63(2):79-83. PubMed ID: 23447078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
